Brooklyn, New York, June 08, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Digital Therapeutics for Mental Health Market is projected to grow at a CAGR of 28.5% from 2023 to 2028.
The increasing acknowledgment and approval of digital therapeutics by regulatory authorities and insurance providers are anticipated to propel market growth. Additionally, the rise in research and development initiatives and investments by major players in the field of digital therapeutics for mental health disorders are expected to contribute to the market's expansion throughout the forecast period.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on “Global Digital Therapeutics for Mental Health Market - Forecast to 2028’’
Key Market Insights
- As per the application outlook, the treatment/care-related segment is expected to be the largest segment in the global digital therapeutics for mental health market from 2023 to 2028
- As per the disease indication outlook, the anxiety disorder segment is expected to be the largest segment in the global digital therapeutics for mental health market from 2023 to 2028
- The Asia Pacific region is analyzed to be the fastest-growing segment in the market.
- North America has the largest share in the market during the forecast period of 2023-2028
- Noom, Teladoc Health, Omada Health, WellDoc, Pear Therapeutics, COGNIFIT, Ginger, Propeller Health, 2morrow, and Canary Health, among others, are some of the key players in the global digital therapeutics for mental health market
Request for a sample copy of the report @ https://www.globalmarketestimates.com/market-report/digital-therapeutics-dtx-for-mental-health-market-4008
Application Outlook (Revenue, USD Billion, 2023-2028)
- Treatment/Care Related
- Preventive Care
Disease Indication Outlook (Revenue, USD Billion, 2023-2028)
- Anxiety Disorder
- Depression
- Bipolar Disorder
- Post-Traumatic Stress Disorder
- Others
Sales Channel Outlook (Revenue, USD Billion, 2023-2028)
- Payers
- Pharmaceutical Companies
- Providers
- Caregivers
- Patients
By Regional Outlook (Revenue, USD Billion, 2023-2028)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Thailand
- Indonesia
- Malaysia
- Singapore
- Vietnam
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Chile
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of MEA
Contact: Yash Jain
Director- Global Accounts & Strategic Advisory
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238
LinkedIn: https://www.linkedin.com/in/yash-jain-global-market-estimates/
Website: www.globalmarketestimates.com
